Vindesine Sulfate — Drug Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

2 Recruiting

3 Completed trials

6 Sponsors

15 Countries

Phase III

Phase II/III

Phase III: 6 Phase II/III: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Neuroblastoma 1

Sponsors using this IMP

Universitaetsklinikum Muenster AöR 2 Charite Universitaetsmedizin Berlin KöR 1 Medical University Of Lodz 1 Medical University Of Silesia Katowice Poland 1 Universitaetsklinikum Schleswig-Holstein 1 University Of Cologne 1

All trials

7 total

IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Phase III 11 countries Charite Universitaetsmedizin Berlin KöR
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending

2024-517295-37-00 Phase III 1 country University Of Cologne
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Phase II/III 1 country Medical University Of Lodz
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Phase III 14 countries Universitaetsklinikum Muenster AöR
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 Phase III 5 countries Universitaetsklinikum Schleswig-Holstein
B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended

2023-505509-18-00 Phase III 7 countries Universitaetsklinikum Muenster AöR

Showing 1–7 of 7 trials

← All drugs A–Z